DYNATRONICS CORPDYNTQ

時価総額
$5.5万
PER
理学療法・リハビリ向け医療機器の有力企業。整形用ソフトブレースや治療用テーブルなど約2,500製品を展開。大株主が2024年6月30日時点で議決権約23%を保有。米国中心に300以上の代理店を通じて展開。
2012年
6月30日
2013年
6月30日
2014年
6月30日
2016年
6月30日
2017年
6月30日
2018年
6月30日
2019年
6月30日
2022年
6月30日
2023年
6月30日
2024年
6月30日
Cash and cash equivalents278,263302,050332,800966,183254,7052155,520550,110398,797483,918
Restricted cash------100,510151,207154,07350,410
Trade accounts receivable, less allowance for credit losses of $48,997 and $131,403 as of June 30, 2024 and 2023, respectively3,667,0863,246,7123,165,3963,523,731-87543
Other receivables-------446,49339,678454,390
Inventories, net6,098,5976,407,5536,157,8484,997,254-11121276
Prepaid expenses---256,735-778,654632,061590,820701,456530,356
Total current assets10,654,15810,879,44910,378,9279,754,849-2120191211
Property and equipment, net3,677,8983,324,9472,980,6774,777,565-66322
Operating lease assets-------243
Intangible assets, net324,715280,078235,440160,123-76443
Goodwill-----77777
Other assets482,719422,672396,456580,161-532,872516,841373,740829,049465,505
Total assets15,270,93015,104,58714,295,14415,272,698-4240353026
Accounts payable-------653
Accrued payroll and benefits expense215,218216,266243,3941,034,688-211877,781566,443
Accrued expense386,229347,221342,716358,787-830,2431862,438891,467725,727
Warranty reserve181,000178,148157,753152,605-205,850207,988197,156115,637120,677
Line of credit3,497,5973,496,3903,521,209--67--2
Finance Lease, Liability, Current-------321,085286,522302,998
Current portion of deferred gain-------150,448150,448150,448
Current portion of operating lease liability-------846,30411
Other liabilities-------23,96713,744-
Total current liabilities7,088,3007,333,8617,031,3323,934,350-15141088
Finance Lease, Liability, Noncurrent-------221
Deferred gain, net of current portion--------777,314626,866
Operating lease liability, net of current portion-------727,31032
Other liabilities---------189,861
Total liabilities9,004,6158,895,6378,286,4659,684,688-2119141312
Preferred stock, no par value: Authorized 50,000,000 shares; 3,351,000 shares issued and outstanding as of June 30, 2022 and June 30, 2021---3,708,152-1212888
Common stock, no par value: Authorized 100,000,000 shares; 5,308,519 shares and 4,044,984 shares issued and outstanding as of June 30, 2024 and 2023, respectively7,091,9357,078,9417,149,8127,545,880-2021343435
Accumulated deficit-825,620-869,991-1,141,133-5,666,022--10,490,141-12,206,213-19,815,233-25,479,577-28,908,169
Total stockholders' equity6,266,3156,208,9506,008,6795,588,010-2121221714
Total liabilities and stockholders' equity15,270,93015,104,58714,295,14415,272,698-4240353026